Clinical Research Study of Autologous Stem Cell Transplantation for Sickle Cell Disease (SCD) Using Peripheral Blood CD34+ Cells Modified With the Lenti/G-βAS3-FB Lentiviral Vector
Investigator(s):
Gary Schiller, M.D.;
Organization:
UCLA
NCT Number:
Disease Name:
Sickle Cell Disease
Trial Phases:
Phase 1
Trial Status:
Recruiting
Trial Contact:
Bruck Habtemariam
BHabtemariam@mednet.ucla.edu